Feifei Li
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- RNA modifications and cancer
- RNA Research and Splicing
- Microbial Metabolic Engineering and Bioproduction
- Circular RNAs in diseases
- RNA Interference and Gene Delivery
Papers in
-
- RNA modifications and cancer 12
- Genomics and Chromatin Dynamics 9
- Bone Metabolism and Diseases 7
- RNA Research and Splicing 6
-
- Cancer-related molecular mechanisms research 12
- MicroRNA in disease regulation 11
- Co-authors
- Changqi Zhao (3 shared papers)Lili Wang (3 shared papers)Na Zhang (1 shared paper)Zhihua Zhang (8 shared papers)Qiping Zheng (4 shared papers)Liancheng Zhu (9 shared papers)Ying‐Jin Yuan (2 shared papers)Changyou Gao (3 shared papers)
- Journals
- Clinical & Experimental Immunology (4 papers)Frontiers in Microbiology (2 papers)Cell Reports (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Frontiers in Bioengineering and Biotechnology (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Feifei Li
112 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 134
- Cancer Research 453
- Molecular Biology 1.4k
- Rheumatology 168
- Pharmacology 81
- Oncology 241
Countries citing papers authored by Feifei Li
This map shows the geographic impact of Feifei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Li more than expected).
Fields of papers citing papers by Feifei Li
This network shows the impact of papers produced by Feifei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Li. The network helps show where Feifei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 109 | |
| 2 | 2018 | 97 | |
| 3 | 2019 | 92 | |
| 4 | 2015 | 84 | |
| 5 | 2014 | 71 | |
| 6 | 2018 | 66 | |
| 7 | 2011 | 63 | |
| 8 | 2013 | 60 | |
| 9 | 2011 | 60 | |
| 10 | 2017 | 56 | |
| 11 | 2016 | 53 | |
| 12 | 2009 | 49 | |
| 13 | 2013 | 49 | |
| 14 | 2018 | 48 | |
| 15 | 2015 | 44 | |
| 16 | 2022 | 37 | |
| 17 | 2021 | 36 | |
| 18 | 2022 | 34 | |
| 19 | 2013 | 32 | |
| 20 | 2019 | 32 |
About Feifei Li
Feifei Li is a scholar working on Molecular Biology, Cancer Research, Rheumatology, Surgery and Oncology, having authored 120 papers that have together received 2.2k indexed citations. Recurring topics across this work include RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (11 papers), Genomics and Chromatin Dynamics (9 papers), Osteoarthritis Treatment and Mechanisms (7 papers), Bone Metabolism and Diseases (7 papers), RNA Research and Splicing (6 papers) and Autophagy in Disease and Therapy (6 papers). The work is most often cited by research in Cancer Research (453 citations), Molecular Biology (1.4k citations), Rheumatology (168 citations), Pharmacology (81 citations) and Oncology (241 citations). Feifei Li has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Changqi Zhao, Lili Wang, Na Zhang, Zhihua Zhang, Qiping Zheng, Liancheng Zhu, Ying‐Jin Yuan, Changyou Gao, Lie Ma and Jianjun Qiao. Their work appears in journals such as Clinical & Experimental Immunology, Frontiers in Microbiology, Cell Reports, Bioorganic & Medicinal Chemistry Letters and Frontiers in Bioengineering and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.